Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  pegylated recombinant human hyaluronidase PH20
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
S1313, Combination Chemotherapy with or without PEGPH20 in Treating Patients with Newly Diagnosed Metastatic Pancreatic Cancer
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: S1313, NCI-2013-01776, NCT01959139
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Subjects With Stage IV Untreated Pancreatic Cancer
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: HALO-109-202, NCI-2013-01369, NCT01839487
PEGPH20 and Cetuximab before Surgery in Treating Patients with Pancreatic Cancer That Can Be Removed by Surgery
Phase: No phase specified
Type: Diagnostic, Treatment
Age: 18 and over
Trial IDs: 14-039, NCI-2014-01977, NCT02241187
Start Over